226 related articles for article (PubMed ID: 31797520)
21. Retroperitoneal lymph node dissection in patients with low stage testicular cancer with embryonal carcinoma predominance and/or lymphovascular invasion.
Stephenson AJ; Bosl GJ; Bajorin DF; Stasi J; Motzer RJ; Sheinfeld J
J Urol; 2005 Aug; 174(2):557-60; discussion 560. PubMed ID: 16006891
[TBL] [Abstract][Full Text] [Related]
22. Long-term follow-up after risk-adapted treatment in clinical stage 1 (CS1) nonseminomatous germ-cell testicular cancer (NSGCT) implementing adjuvant CVB chemotherapy. A SWENOTECA study.
Tandstad T; Cohn-Cedermark G; Dahl O; Stierner U; Cavallin-Stahl E; Bremnes RM; Klepp O
Ann Oncol; 2010 Sep; 21(9):1858-1863. PubMed ID: 20142410
[TBL] [Abstract][Full Text] [Related]
23. A systematic review and meta-analysis of lymphovascular invasion in patients treated with radical cystectomy for bladder cancer.
Mari A; Kimura S; Foerster B; Abufaraj M; D'Andrea D; Gust KM; Shariat SF
Urol Oncol; 2018 Jun; 36(6):293-305. PubMed ID: 29685374
[TBL] [Abstract][Full Text] [Related]
24. Outcome of patients with stage II and III nonseminomatous germ cell tumors: results of a single center.
Ataergin S; Ozet A; Arpaci F; Kilic S; Beyzadeoglu M; Komurcu S
Indian J Cancer; 2007; 44(1):6-11. PubMed ID: 17401218
[TBL] [Abstract][Full Text] [Related]
25. Treatment of Relapse of Clinical Stage I Nonseminomatous Germ Cell Tumors on Surveillance.
Hamilton RJ; Nayan M; Anson-Cartwright L; Atenafu EG; Bedard PL; Hansen A; Chung P; Warde P; Sweet J; O'Malley M; Sturgeon J; Jewett MAS
J Clin Oncol; 2019 Aug; 37(22):1919-1926. PubMed ID: 30802156
[TBL] [Abstract][Full Text] [Related]
26. Percentage of embryonal carcinoma and of vascular invasion predicts pathological stage in clinical stage I nonseminomatous testicular cancer.
Moul JW; McCarthy WF; Fernandez EB; Sesterhenn IA
Cancer Res; 1994 Jan; 54(2):362-4. PubMed ID: 8275469
[TBL] [Abstract][Full Text] [Related]
27. Predictors of positive retroperitoneal lymph nodes in patients with high risk testicular cancer.
Williams SB; Kacker R; Winston D; Bahnson E; Steele GS; Richie JP
J Urol; 2011 Dec; 186(6):2245-8. PubMed ID: 22014805
[TBL] [Abstract][Full Text] [Related]
28. Predictors of occult metastasis in clinical stage I nonseminoma: a systematic review.
Vergouwe Y; Steyerberg EW; Eijkemans MJ; Albers P; Habbema JD
J Clin Oncol; 2003 Nov; 21(22):4092-9. PubMed ID: 14559885
[TBL] [Abstract][Full Text] [Related]
29. Outcomes of surveillance protocol of clinical stage I nonseminomatous germ cell tumors-is shift to risk adapted policy justified?
Divrik RT; Akdoğan B; Ozen H; Zorlu F
J Urol; 2006 Oct; 176(4 Pt 1):1424-29; discussion 1429-30. PubMed ID: 16952649
[TBL] [Abstract][Full Text] [Related]
30. The Significance of Spermatic Cord Involvement by Testicular Germ Cell Tumors: Should We Be Staging Discontinuous Invasion From Involved Lymphovascular Spaces Differently From Direct Extension?
Sanfrancesco JM; Trevino KE; Xu H; Ulbright TM; Idrees MT
Am J Surg Pathol; 2018 Mar; 42(3):306-311. PubMed ID: 29309304
[TBL] [Abstract][Full Text] [Related]
31. Surveillance for patients with clinical stage I nonseminomatous testicular germ cell tumors.
Li X; Guo S; Wu Z; Dong P; Li Y; Zhang Z; Yao K; Han H; Qin Z; Zhou F; Liu Z
World J Urol; 2015 Sep; 33(9):1351-7. PubMed ID: 25471669
[TBL] [Abstract][Full Text] [Related]
32. Testicular germ cell tumors: revisiting a series in light of the new WHO classification and AJCC staging systems, focusing on challenges for pathologists.
Lobo J; Costa AL; Vilela-Salgueiro B; Rodrigues Â; Guimarães R; Cantante M; Lopes P; Antunes L; Jerónimo C; Henrique R
Hum Pathol; 2018 Dec; 82():113-124. PubMed ID: 30041024
[TBL] [Abstract][Full Text] [Related]
33. Defining a New Prognostic Index for Stage I Nonseminomatous Germ Cell Tumors Using CXCL12 Expression and Proportion of Embryonal Carcinoma.
Gilbert DC; Al-Saadi R; Thway K; Chandler I; Berney D; Gabe R; Stenning SP; Sweet J; Huddart R; Shipley JM
Clin Cancer Res; 2016 Mar; 22(5):1265-73. PubMed ID: 26453693
[TBL] [Abstract][Full Text] [Related]
34. Clinical stage I nonseminomatous and mixed germ cell tumors of the testis. A clinicopathologic study of 93 patients on a surveillance protocol after orchiectomy alone.
Dunphy CH; Ayala AG; Swanson DA; Ro JY; Logothetis C
Cancer; 1988 Sep; 62(6):1202-6. PubMed ID: 2842034
[TBL] [Abstract][Full Text] [Related]
35. Vascular invasion as a prognosticator of metastatic disease in nonseminomatous germ cell tumors of the testis. Importance in "surveillance only" protocols.
Moriyama N; Daly JJ; Keating MA; Lin CW; Prout GR
Cancer; 1985 Nov; 56(10):2492-8. PubMed ID: 2412688
[TBL] [Abstract][Full Text] [Related]
36. Epidermal growth factor receptor and epididymis invasion as prognostic biomarkers in clinical stage I testicular germ cell tumours.
Sanmamed MF; Esteban E; Uriol E; Zarate R; Capelan M; Muriel C; Crespo G; Berros JP; Pardo-Coto P; Perez Q; Alvarez-Fernández C; Jiménez Fonseca P; Luque M; Astudillo A
J Transl Med; 2017 Mar; 15(1):62. PubMed ID: 28320414
[TBL] [Abstract][Full Text] [Related]
37. Management of patients with low-stage nonseminomatous germ cell testicular cancer.
Stephenson AJ; Sheinfeld J
Curr Treat Options Oncol; 2005 Sep; 6(5):367-77. PubMed ID: 16107240
[TBL] [Abstract][Full Text] [Related]
38. Stage I nonseminomatous germ cell testicular tumor: prediction of metastatic potential by primary histopathology.
Fung CY; Kalish LA; Brodsky GL; Richie JP; Garnick MB
J Clin Oncol; 1988 Sep; 6(9):1467-73. PubMed ID: 2843611
[TBL] [Abstract][Full Text] [Related]
39. Rete Testis Invasion Is Consistent With Pathologic Stage T1 in Germ Cell Tumors.
Farooq A; Jorda M; Whittington E; Kryvenko ON; Braunhut BL; Pavan N; Procházková K; Zhang L; Rai S; Miller T; Liu J; Szabo A; Iczkowski KA
Am J Clin Pathol; 2019 Apr; 151(5):479-485. PubMed ID: 30576407
[TBL] [Abstract][Full Text] [Related]
40. Comparative Effectiveness of Risk-adapted Surveillance vs Retroperitoneal Lymph Node Dissection in Clinical Stage I Nonseminomatous Germ Cell Testicular Cancer: A Retrospective Follow-up Study of 81 Patients.
Fan G; Zhang L; Yi L; Jiang ZQ; Ke Y; Wang XS; Xiong YY; Han WQ; Zhou X; Liu C; Yu X
Asian Pac J Cancer Prev; 2015; 16(8):3267-72. PubMed ID: 25921130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
